0001193125-12-086238.txt : 20120229 0001193125-12-086238.hdr.sgml : 20120229 20120228193707 ACCESSION NUMBER: 0001193125-12-086238 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20120229 DATE AS OF CHANGE: 20120228 EFFECTIVENESS DATE: 20120229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DENDREON CORP CENTRAL INDEX KEY: 0001107332 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223203193 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-179780 FILM NUMBER: 12649592 BUSINESS ADDRESS: STREET 1: 1301 2ND AVE. STREET 2: SUITE 3200 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: 206-219-7815 MAIL ADDRESS: STREET 1: 1301 2ND AVE. STREET 2: SUITE 3200 CITY: SEATTLE STATE: WA ZIP: 98101 S-8 1 d307231ds8.htm FORM S-8 Form S-8

As filed with the Securities and Exchange Commission on February 29, 2012

Registration No. 333-                    

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM S-8

REGISTRATION STATEMENT

Under

The Securities Act of 1933

 

 

DENDREON CORPORATION

(Exact name of Registrant as specified in its charter)

 

 

 

Delaware   1301 2nd Avenue, Suite 3200   22-3203193

(State or other jurisdiction of

incorporation or organization)

 

Seattle, WA 98101

(206) 256-4545

 

(I.R.S. Employer

Identification Number)

(Address, including zip code, of principal executive offices)

 

 

2012 Equity Incentive Inducement Award Plan

(Full title of the plan)

Esmé C. Smith

Vice President, Deputy General Counsel and Assistant Secretary

Dendreon Corporation

1301 2nd Avenue, Suite 3200

Seattle, Washington 98101

(Name and address of agent for service)

 

 

(206) 256-4545

(Telephone number, including area code, of agent for service)

 

 

Copy to:

Patrick J. Schultheis, Esq.

Wilson Sonsini Goodrich & Rosati

Professional Corporation

701 Fifth Avenue, Suite 5100

Seattle, WA 98104

(206) 883-2500

 

 

CALCULATION OF REGISTRATION FEE

 

Title of Each Class of
Securities to be Registered
  

Amount

to be

Registered (1)

   Proposed
Maximum
Offering Price
Per Share (2)
   Proposed
Maximum
Aggregate
Offering Price
   Amount of
Registration Fee

Common Stock ($0.001 par value) (3)

   3,000,000    $12.82    $38,460,000    $4,407.52

 

 

(1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of Common Stock which become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration which results in an increase in the number of the outstanding shares of Common Stock.
(2) The estimated Proposed Maximum Offering Price Per Share was determined pursuant to Rule 457(h) to be the average of the high and low sales prices reported on the Nasdaq Stock Market on February 27, 2012.
(3) Includes related preferred stock purchase rights under the company’s Rights Agreement relating to its Series A Junior Participating Preferred Stock, par value $.001 per share.

 

 

 


PART I

 

Item 1. Plan Information.*

 

Item 2. Registration Information and Employee Plan Annual Information.*

Upon written or oral request, we will provide, without charge, the documents incorporated by reference in Item 3 of Part II of this Registration Statement. The documents are incorporated by reference in the Section 10(a) prospectus. We will also provide, without charge, upon written or oral request, other documents required to be delivered to employees pursuant to Rule 428 under the Securities Act of 1933, as amended (the “Securities Act”). Requests for the above-referenced information should be directed to Dendreon Corporation, 1301 2nd Avenue, Suite 3200, Seattle, Washington 98101 Attention: Corporate Secretary, telephone number (206) 256-4545.

 

* Information required by Part I of Form S-8 to be contained in a prospectus meeting the requirements of Section 10(a) of the Securities Act is not required to be filed with the Securities and Exchange Commission (“Commission”) and is omitted from this Registration Statement in accordance with Rule 428 under the Securities Act and the explanatory note to Part I of Form S-8. Such information will be sent or given to employees as specified by Rule 428(b)(1) under the Securities Act.

PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

 

Item 3. Incorporation of Documents by Reference.

The following documents and information previously filed with the Securities and Exchange Commission (the “SEC”) by the registrant are hereby incorporated by reference in this registration statement:

 

  (a) The company’s annual report on Form 10-K filed pursuant to Sections 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), containing audited financial statements for the company’s latest fiscal year ended December 31, 2011, as filed with the SEC on February 29, 2012.

 

  (b) All other reports filed pursuant to Section 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by the company’s last filing on Form 10-K referred to in (a) above.

 

  (c) The description of our common stock set forth in our Registration Statement on Form S-1, which was filed with the SEC on March 8, 2000 (File No. 333-31920), and the description of the company’s Series A Junior Participating Preferred Stock set forth in our Current Report on Form 8-K, as filed with the SEC on September 25, 2002 (File No. 000-30681), and in Exhibit 4.1 thereto.

In addition, all documents filed by the company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act subsequent to the filing of this registration statement, and prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this registration statement and to be part hereof from the date of filing such documents.

 

II-1


Under no circumstances will any information furnished under current items 2.02 or 7.01 of Form 8-K be deemed incorporated herein by reference unless such Form 8-K expressly provides to the contrary.

Any statement contained in a report or document incorporated or deemed to be incorporated by reference into this Registration Statement shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed report or document which is also or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

 

Item 4. Description of Securities.

Not applicable.

 

Item 5. Interests of Named Experts and Counsel.

Not applicable.

 

Item 6. Indemnification of Directors and Officers.

Section 145 of the Delaware General Corporation Law (the “DGCL”) authorizes a court to award, or a corporation’s board of directors to grant, indemnification to directors and officers in terms sufficiently broad to permit such indemnification under certain circumstances for liabilities (including reimbursement for expenses incurred) arising under the Securities Act of 1933. The company’s bylaws provide for mandatory indemnification of its directors and officers and permissible indemnification of employees and other agents to the maximum extent not prohibited by the DGCL. The company’s certificate of incorporation provides that, pursuant to Delaware law, its directors shall not be liable for monetary damages for breach of the directors’ fiduciary duty as directors to the company and its stockholders. This provision in the certificate of incorporation does not eliminate the directors’ fiduciary duty, and in appropriate circumstances equitable remedies such as injunctive or other forms of non-monetary relief will remain available under Delaware law. In addition, each director will continue to be subject to liability for breach of the director’s duty of loyalty to the company for acts or omissions not in good faith or involving intentional misconduct, for knowing violations of law, for actions leading to improper personal benefit to the director and for payment of dividends or approval of stock repurchases or redemptions that are unlawful under Delaware law. The provision also does not affect a director’s responsibilities under any other law, such as the federal securities laws or state or federal environmental laws. The company has entered into indemnification agreements with its officers and directors. The indemnification agreements provide its officers and directors with further indemnification to the maximum extent permitted by the DGCL. The company maintains liability insurance for its directors and officers.

 

Item 7. Exemption from Registration Claimed.

Not applicable.

 

II-2


Item 8. Exhibits.

 

Exhibit
    Number     
  

Description

  4.1    Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 filed with the registrant’s Form 10-Q, filed with the Securities and Exchange Commission on May 14, 2002).
  4.2    Certificate of Amendment to Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the registrant’s Form 8-K, filed with the Securities and Exchange Commission on June 13, 2005).
  4.3    Certificate of Amendment to Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the registrant’s Form 8-K, filed with the Securities and Exchange Commission on June 16, 2009).
  4.4    Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the registrant’s Form 8-K, filed with the Securities and Exchange Commission on December 7, 2011).
  4.5    Specimen Common Stock certificate (incorporated by reference to Exhibit 4.1 to Amendment No. 1 to the registrant’s Registration Statement on Form S-1 (filed with the Securities and Exchange Commission on May 22, 2000).
  4.6    Certificate of Designation of Series A Junior Participating Preferred Stock (incorporated by reference to Exhibit 4.1 to the registrant’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on September 25, 2002).
  4.7    Rights Agreement between the registrant and Mellon Investor Services, LLC, as Rights Agent, dated September 18, 2002 (incorporated by reference to Exhibit 99.2 to the registrant’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on September 25, 2002).
  4.8    Form of Rights Certificate (incorporated by reference to Exhibit 99.3 to the registrant’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on September 25, 2002).
  5.1    Opinion of Wilson Sonsini Goodrich & Rosati, Professional Corporation.
23.1    Consent of Independent Registered Public Accounting Firm.
23.2    Consent of Counsel (contained in Exhibit 5.1).
24.1    Power of Attorney (see Page II-5).
99.1    Dendreon Corporation 2012 Equity Incentive Inducement Award Plan (incorporated by reference to Exhibit 10.1 to the registrant’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on January 19, 2012).

 

Item 9. Undertakings.

(a) The undersigned registrant hereby undertakes:

1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

(i) To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;

 

II-3


(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement;

(iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement.

2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

(b) The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant’s annual report pursuant to section 13(a) or section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

(c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the indemnification provisions summarized in Item 6, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

 

II-4


SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Seattle, State of Washington, on February 28, 2012.

 

DENDREON CORPORATION
By:   /s/ Gregory T. Schiffman
  Gregory T. Schiffman
  Executive Vice President and Chief Financial Officer

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Gregory T. Schiffman and John H. Johnson and each of them, their true and lawful attorneys and agents, with full power of substitution, each with power to act alone, to sign and execute on behalf of the undersigned any amendment or amendments to this Registration Statement on Form S-8 and to perform any acts necessary in order to file such amendments, and each of the undersigned does hereby ratify and confirm all that said attorneys and agents, or their or his or her substitutes, shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

SIGNATURE

  

TITLE

 

DATE

/s/ John H. Johnson

John H. Johnson

   Director, President and Chief Executive Officer (Principal Executive Officer)   February 28, 2012

/s/ Gregory T. Schiffman

Gregory T. Schiffman

  

Executive Vice President and Chief Financial Officer

  February 28, 2012

/s/ Gregory R. Cox

Gregory R. Cox

  

Vice President, Finance (Principal Financial Officer)

  February 28, 2012

/s/ Mitchell H. Gold

Mitchell H. Gold

  

Executive Chairman of the Board

  February 28, 2012

/s/ Susan S. Bayh

Susan B. Bayh

  

Director

  February 28, 2012

/s/ Richard B. Brewer

Richard B. Brewer

  

Director

  February 28, 2012

/s/ Gerardo Canet

Gerardo Canet

  

Director

  February 28, 2012

 

II-5


SIGNATURE

  

TITLE

 

DATE

/s/ Bogdan Dziurzynski

Bogdan Dziurzynski

  

Director

  February 28, 2012

/s/ Dennis M. Fenton

Dennis M. Fenton

  

Director

  February 28, 2012

/s/ Pedro Granadillo

Pedro Granadillo

  

Director

  February 28, 2012

/s/ David C. Stump

David C. Stump

  

Director

  February 28, 2012

/s/ David L. Urdal

David L. Urdal

  

Director

  February 28, 2012

/s/ Douglas G. Watson

Douglas G. Watson

  

Lead Independent Director

  February 28, 2012

 

II-6


INDEX TO EXHIBITS

 

Exhibit
Number
  

Description

  4.1    Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 filed with the registrant’s Form 10-Q, filed with the Securities and Exchange Commission on May 14, 2002).
  4.2    Certificate of Amendment to Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the registrant’s Form 8-K, filed with the Securities and Exchange Commission on June 13, 2005).
  4.3    Certificate of Amendment to Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the registrant’s Form 8-K, filed with the Securities and Exchange Commission on June 16, 2009).
  4.4    Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the registrant’s Form 8-K, filed with the Securities and Exchange Commission on December 7, 2011).
  4.5    Specimen Common Stock certificate (incorporated by reference to Exhibit 4.1 to Amendment No. 1 to the registrant’s Registration Statement on Form S-1 (filed with the Securities and Exchange Commission on May 22, 2000).
  4.6    Certificate of Designation of Series A Junior Participating Preferred Stock (incorporated by reference to Exhibit 4.1 to the registrant’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on September 25, 2002).
  4.7    Rights Agreement between the registrant and Mellon Investor Services, LLC, as Rights Agent, dated September 18, 2002 (incorporated by reference to Exhibit 99.2 to the registrant’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on September 25, 2002).
  4.8    Form of Rights Certificate (incorporated by reference to Exhibit 99.3 to the registrant’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on September 25, 2002).
  5.1    Opinion of Wilson Sonsini Goodrich & Rosati, Professional Corporation.
23.1    Consent of Independent Registered Public Accounting Firm.
23.2    Consent of Counsel (contained in Exhibit 5.1).
24.1    Power of Attorney (see Page II-5).
99.1    Dendreon Corporation 2012 Equity Incentive Inducement Award Plan (incorporated by reference to Exhibit 10.1 to the registrant’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on January 19, 2012).

 

II-7

EX-5.1 2 d307231dex51.htm OPINION OF WILSON SONSINI GOODRICH & ROSATI, PROFESSIONAL CORPORATION <![CDATA[Opinion of Wilson Sonsini Goodrich & Rosati, Professional Corporation]]>

Exhibit 5.1

February 28, 2012

Dendreon Corporation

1301 2nd Avenue, Suite 3200

Seattle, Washington 98101

 

  RE: REGISTRATION STATEMENT ON FORM S-8

Ladies and Gentlemen:

We have acted as counsel to Dendreon Corporation, a Delaware corporation (the “Company” or “you”) and have examined the Registration Statement on Form S-8 to be filed by you with the Securities and Exchange Commission on or about the date hereof (the “Registration Statement”), in connection with the registration under the Securities Act of 1933, as amended, of 3,000,000 shares of Dendreon Corporation Common Stock, par value $0.001 per share (the “Shares”) reserved for issuance under the Dendreon Corporation 2012 Equity Incentive Inducement Award Plan (the “Plan”) and the related preferred stock purchase rights (together with the Shares, the “Securities”). As your legal counsel, we have reviewed the actions proposed to be taken by you in connection with the issuance and sale of the Securities to be issued under the Plan.

It is our opinion that the Securities, when issued and sold in the manner referred to in the Plan and pursuant to the agreements that accompany the Plan, will be legally and validly issued, fully paid and nonassessable.

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the use of our name wherever it appears in the Registration Statement.

Very truly yours,

/s/ WILSON SONSINI GOODRICH & ROSATI

WILSON SONSINI GOODRICH & ROSATI

Professional Corporation

EX-23.1 3 d307231dex231.htm CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Consent of Independent Registered Public Accounting Firm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the Dendreon Corporation 2012 Equity Incentive Inducement Award Plan of our reports dated February 28, 2012, with respect to the consolidated financial statements of Dendreon Corporation and the effectiveness of internal control over financial reporting of Dendreon Corporation included in its Annual Report (Form 10-K) for the year ended December 31, 2011, filed with the Securities and Exchange Commission.

 

/s/ Ernst & Young LLP
Seattle, Washington
February 28, 2012